Infantile Refsum Disease
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Infantile Refsum Disease

What is the definition of Infantile Refsum Disease?
Infantile Refsum disease is the mildest of a group of disorders known as peroxisome biogenesis disorders, Zellweger syndrome spectrum (PBD-ZSS). PBD-ZSS is a group of inherited genetic disorders that damage the white matter of the brain and affect motor movements. Peroxisome biogenesis disorders, in turn, are part of a larger group of disorders called leukodystrophies. IRD can cause low muscle tone (hypotonia), retinitis pigmentosa (a visual impairment that can lead to blindness), developmental delay, sensorineural hearing loss, and liver dysfunction. IRD usually presents at birth or in infancy. Most individuals with IRD can achieve motor milestones, though they may be delayed, and most individuals can communicate with a few words or signs. Leukodystrophy with loss of acquired skills can occur at any age and may stabilize or progress. Peroxisome biogenesis disorders are caused by genetic changes in one of the PEX genes and are inherited in an autosomal recessive manner. Adult Refsum disease and infantile refsum disease are separate disorders caused by different genetic defects.
What are the alternative names for Infantile Refsum Disease?
  • Refsum disease, infantile form
  • IRD
  • Infantile Refsum disease
  • Infantile form of phytanic acid storage disease
Who are the top Infantile Refsum Disease Local Doctors?
Marta R. Stella
Experienced in Infantile Refsum Disease
Experienced in Infantile Refsum Disease

Reading Hospital Neurology Suite 2200

420 W Linfield Trappe Rd, Ste 2200, 
Limerick, PA 
Languages Spoken:
English

. Dr. Stella is rated as an Experienced provider by MediFind in the treatment of Infantile Refsum Disease. Her top areas of expertise are Migraine with Brainstem Aura, Transient Ischemic Attack (TIA), Pseudobulbar Affect, and Migraine.

Distinguished in Infantile Refsum Disease
Distinguished in Infantile Refsum Disease
Gifu-shi, JP 

Nobuyuki Shimozawa practices in Gifu-shi, Japan. Mr. Shimozawa is rated as a Distinguished expert by MediFind in the treatment of Infantile Refsum Disease. His top areas of expertise are Zellweger Syndrome, Adrenoleukodystrophy (ALD), Addison's Disease, Peroxisomal Acyl-CoA Oxidase Deficiency, and Bone Marrow Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Infantile Refsum Disease
Neurology
Distinguished in Infantile Refsum Disease
Neurology

Office

527 Medical Park Dr Ste 107, 
Bridgeport, WV 
Languages Spoken:
English

Shiv Navada is a Neurologist in Bridgeport, West Virginia. Dr. Navada is rated as a Distinguished provider by MediFind in the treatment of Infantile Refsum Disease. His top areas of expertise are Infantile Refsum Disease, Refsum Disease, Spastic Paraplegia Type 3A, and Spastic Paraplegia Type 4.

What are the latest Infantile Refsum Disease Clinical Trials?
The Myelin Disorders Biorepository Project and Global Leukodystrophy Initiative Clinical Trials Network

Summary: The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepo...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Coordination of Rare Diseases at Sanford

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center